# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3816980 | F | Antiviral activity against human rhinovirus 2 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A2 | 9 | ALA3813594 | organism-based format | Scientific Literature | |
2. | ALA3816981 | F | Antiviral activity against human rhinovirus 16 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A16 | 9 | ALA3813594 | organism-based format | Scientific Literature | |
3. | ALA3816982 | F | Antiviral activity against human rhinovirus 17 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | Human rhinovirus B17 | 9 | ALA3813594 | cell-based format | Scientific Literature | |
4. | ALA3816128 | F | Antiviral activity against human rhinovirus 8 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | Human rhinovirus A8 | 5 | ALA3813594 | cell-based format | Scientific Literature | |
5. | ALA3816129 | F | Antiviral activity against human rhinovirus 14 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus B14 | 5 | ALA3813594 | organism-based format | Scientific Literature | |
6. | ALA3816130 | F | Antiviral activity against human rhinovirus 25 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A25 | 5 | ALA3813594 | organism-based format | Scientific Literature | |
7. | ALA3816131 | F | Antiviral activity against human rhinovirus 41 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A41 | 5 | ALA3813594 | organism-based format | Scientific Literature | |
8. | ALA3816132 | F | Antiviral activity against human rhinovirus 85 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | rhinovirus A85 | 5 | ALA3813594 | organism-based format | Scientific Literature | |
9. | ALA3816133 | F | Antiviral activity against human rhinovirus 100 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | Human rhinovirus A100 | 5 | ALA3813594 | cell-based format | Scientific Literature | |
10. | ALA3816137 | F | Antiviral activity against human rhinovirus 7 assessed as reduction in viral infection in human HeLa H1 cells pretreated for 1 to 2 hrs with virus followed by cell addition measured after 48 hrs by Celltiter-Glo reagent based assay | Human rhinovirus A7 | 5 | ALA3813594 | cell-based format | Scientific Literature |